| Price | 0.05 |
| Price Change Today | +$0.01 (+25.00%) |
| P&P rating | ![]() |
| Zacks Rank | N/A - N/A |
| Open Price | $0.04 |
| Previous Close | $0.04 |
| Daily Range | $0.04 - $0.05 |
| 52-Week Range | $0.01 - $1.03 |
| Volume | 488,098 |
| BIONOVO INC is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, which are markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California | |




